Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System
Sponsor: Ortho Development Corporation
Listed as NCT03986918, this observational or N/A phase trial focuses on Avascular Necrosis of Hip and Joint Diseases and remains ongoing. Sponsored by Ortho Development Corporation, it has been updated 6 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Aug 2024 — Sep 2024 [monthly]
Unknown
Status: Recruiting → Unknown
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Jan 2021 — Jul 2024 [monthly]
Recruiting
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
▶ Show 1 earlier version
-
Jul 2019 — Feb 2020 [monthly]
Recruiting
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ortho Development Corporation
For direct contact, visit the study record on ClinicalTrials.gov .